medigraphic.com
ENGLISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2019, Número 5

<< Anterior Siguiente >>

salud publica mex 2019; 61 (5)


Perfil de Proyecto: Un estudio multicéntrico sobre el cáncer de mama en mujeres jóvenes en América Latina (estudio PRECAMA)

Romieu I, Biessy C, Torres-Mejía G, Ángeles-Llerenas A, Sánchez GI, Borrero M, Ossa CA, Porras C, Rodríguez AC, Ocampo R, Garmendia ML, Bustamante E, Olivier M, Porter P, Rinaldi S
Texto completo Cómo citar este artículo Artículos similares

Idioma: Ingles.
Referencias bibliográficas: 47
Paginas: 601-608
Archivo PDF: 270.07 Kb.


PALABRAS CLAVE

cáncer de mama, mujeres, premenopausia, América Latina, factores de riesgo.

RESUMEN

Objetivo. Describir la justificación y la metodología para el establecimiento de un proyecto multicéntrico sobre el cáncer de mama en mujeres jóvenes de América Latina. Material y métodos. La Agencia Internacional para la Investigación del Cáncer (IARC) ha establecido un estudio colaborativo internacional de casos y controles con base poblacional en cuatro países de América Latina: Chile, Colombia, Costa Rica y México (el estudio PRECAMA). Se han desarrollado metodologías estandarizadas para recolectar información sobre variables reproductivas, estilos de vida, antropometría y dieta, datos clínicos y patológicos y muestras biológicas. Conclusión. PRECAMA es único en su enfoque multidisciplinario. Los datos generados a través de este proyecto serán fundamentales para identificar los principales factores de riesgo del cáncer de mama en mujeres jóvenes. Los ha llazgos serán relevantes para la prevención y los programas de detección oportuna en América Latina, con beneficios clínicos inmediatos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. https:// doi.org/10.1002/ijc.29210

  2. Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011;53(5):372-84 [cited march 25, 2019]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22218791

  3. Villarreal-Garza C, Bargallo-Rocha JE, Soto-Perez-de-Celis E, Lasa- Gonsebatt F, Arce-Salinas C, Lara-Medina F, et al. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat. 2016;157(2):385-94. https://doi.org/10.1007/ s10549-016-3811-2

  4. Franco-Marina F, López-Carrillo L, Keating NL, Arreola-Ornelas H, Marie Knaul F. Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries. Cancer Epidemiol. 2015;39(6):831-7. https://doi.org/10.1016/j.canep.2015.10.004

  5. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable E, et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res. 2008;68(23):9723-8. https://doi.org/10.1158/0008-5472. CAN-08-2039

  6. Fejerman L, Romieu I, John EM, Lazcano-Ponce E, Huntsman S, Beckman KB, et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev. 2010;19(4):1074-82. https://doi.org/10.1158/1055-9965.EPI-09-1193

  7. Porter PL. Global trends in breast cancer incidence and mortality. Salud Publica Mex. 2009;51 Suppl 2:s141-6 [cited march 25, 2019]. Available from: http://saludpublica.mx/index.php/spm/article/view/4881

  8. Lee HB, Han W. Unique features of young age breast cancer and its management. J Breast Cancer. 2014;17(4):301-7. https://doi.org/10.4048/ jbc.2014.17.4.301

  9. Narod SA. Breast cancer in young women. Nat Rev Clin Oncol. 2012;9(8):460-70. https://doi.org/10.1038/nrclinonc.2012.102

  10. Mahoney MC, Bevers T, Linos E, Willett WC. Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J Clin. 2008;58(6):347-71. https://doi.org/10.3322/CA.2008.0016

  11. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186-94. https://doi.org/10.3322/ caac.21225

  12. Brenner DR, Brockton NT, Kotsopoulos J, Cotterchio M, Boucher BA, Courneya KS, et al. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors. Cancer Causes Control. 2016;27(4):459-72. https://doi.org/10.1007/s10552-016-0726-5

  13. Chajes V, Romieu I. Nutrition and breast cancer. Maturitas. 2014;77(1):7-11. https://doi.org/10.1016/j.maturitas.2013.10.004

  14. Romieu I. Diet and breast cancer. Salud Publica Mex. 2011;53(5):430-9 [cited march 25, 2019]. Available from: http://saludpublica.mx/index.php/ spm/article/view/7089

  15. Coronado GD, Beasley J, Livaudais J. Alcohol consumption and the risk of breast cancer. Salud Publica Mex. 2011;53(5):440-7 [cited march 25, 2019]. Available from: http://saludpublica.mx/index.php/spm/article/ view/7090

  16. World Cancer Research Fund, American Institue for Cancer Research. Third Expert report: Diet, Nutrition, Physical Activity and Cancer: a Global Perspective [internet]. WCRF. 2018 [cited march 25, 2019]. Available from: https://www.wcrf.org/dietandcancer/about

  17. Amadou A, Degoul J, Hainaut P, Chajes V, Biessy C, Torres-Mejía G, et al. Dietary carbohydrate, glycemic index, glycemic load, and breast cancer risk among mexican women. Epidemiology. 2015;26(6):917-24. https://doi. org/10.1097/EDE.0000000000000374

  18. Ángeles-Llerenas A, Ortega-Olvera C, Pérez-Rodríguez E, Esparza- Cano JP, Lazcano-Ponce E, Romieu I, et al. Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control. 2010;21(4):577-86. https://doi.org/10.1007/s10552-009-9487-8

  19. Lajous M, Willett W, Lazcano-Ponce E, Sanchez-Zamorano LM, Hernandez-Avila M, Romieu I. Glycemic load, glycemic index, and the risk of breast cancer among Mexican women. Cancer Causes Control. 2005;16(10):1165-9. https://doi.org/10.1007/s10552-005-0355-x

  20. Chajes V, Torres-Mejia G, Biessy C, Ortega-Olvera C, Ángeles-Llerenas A, Ferrari P, et al. omega-3 and omega-6 Polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: impact of obesity status. Cancer Epidemiol Biomarkers Prev. 2012;21(2):319-26. https://doi. org/10.1158/1055-9965.EPI-11-0896

  21. Willett WC. Nutritional Epidemiology, 2nd ed. ed. n, editor. New-York: Oxford University Press, 1998.

  22. Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex. 1998;40(2):133-40 [cited march 25, 2019]. Available from: http://saludpublica. mx/index.php/spm/article/view/6068

  23. Romieu I, Parra S, Hernández JF, Madrigal H, Willett W, Hernández M. Questionnaire assessment of antioxidants and retinol intakes in Mexican women. Arch Med Res. 1999;30(3):224-39 [cited march 25, 2019]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10427874

  24. Kabagambe EK, Baylin A, Allan DA, Siles X, Spiegelman D, Campos H. Application of the method of triads to evaluate the performance of food frequency questionnaires and biomarkers as indicators of longterm dietary intake. Am J Epidemiol. 2001;154(12):1126-35. https://doi. org/10.1093/aje/154.12.1126

  25. Lohman TG RA, Martorell R. Anthropometric standardization reference manual. Champaign IL: Human Kinetics Books, 1988.

  26. Tehard B, van Liere MJ, Com Nougue C, Clavel-Chapelon F. Anthropometric measurements and body silhouette of women: validity and perception. J Am Diet Assoc. 2002;102(12):1779-84. https://doi.org/10.1016/ s0002-8223(02)90381-0

  27. Vaught JB, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010;19(4):912-5. https://doi.org/10.1158/1055-9965.EPI-10-0058

  28. Mendy M, Caboux E, Lawlor RT, Wright J, Wild CP. Common minimum technical standards and protocols for biobanks dedicated to cancer research. Lyon, France: IARC, 2017.

  29. Lee SK, Bae SY, Lee JH, Lee HC, Yi H, Kil WH, et al. Distinguishing low-risk luminal a breast cancer subtypes with Ki-67 and p53 Is More predictive of long-term survival. PLoS One. 2015;10(8):e0124658. https:// doi.org/10.1371/journal.pone.0124658

  30. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736-47. https://doi.org/10.1093/annonc/mdr304

  31. Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, et al. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015;10(3):211-9. https://doi.org/10.1159/000433590

  32. Olivier M, Bouaoun L, Villar S, Robitaille A, Cahais V, Heguy A, et al. Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study. PLoS One. 2019;14(1):e0210372. https://doi.org/10.1371/journal.pone.0210372. eCollection2019

  33. Romieu I, Biessy C, Carayol M, His M, Torres-Mejía G, Sanchez GI, et al. Reproductive factors and molecular subtypes of breast cancer among young women in Latin America: the PRECAMA study. Sci Rep. 2018;8(1):13109. https://doi.org/10.1038/s41598-018-31393-7

  34. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol. 1994;139(8):819-3. https://doi.org/10.1093/oxfordjournals.aje.a117079

  35. Fortner RT, Katzke V, Kuhn T, Kaaks R. Obesity and Breast Cancer. Recent Results Cancer Res. 2016;208:43-65. https://doi.org/10.1007/978- 3-319-42542-9_3

  36. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev. 2003;4(3):157-73. https://doi. org/10.1046/j.1467-789X.2003.00108.x

  37. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665-78. https://doi.org/10.1111/obr.12028

  38. Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses’ Health Study II. J Natl Cancer Inst. 2011;103(3):273-8. https://doi.org/10.1093/jnci/djq500

  39. John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, et al. Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):138-47. https:// doi.org/10.1158/1055-9965.EPI-13-1007-T

  40. Romieu I, Amadou A, Chajes V. The role of diet, physical activity, body fatness, and breastfeeding in breast cancer in young women: epidemiological evidence. Rev Invest Clin. 2017;69(4):193-203 [cited march 25, 2019]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28776604

  41. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis. 2012;33(8):1512-21. https://doi.org/10.1093/ carcin/bgs163

  42. Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107(9):1608-17. https://doi.org/10.1038/bjc.2012.414

  43. Hardefeldt PJ, Edirimanne S, Eslick GD. Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer. 2012;19(6):793-803. https://doi.org/10.1530/ERC-12-0242

  44. Gamboa-Meléndez MA, Huerta-Chagoya A, Moreno-Macías H, Vázquez-Cardenas P, Ordónez-Sánchez ML, Rodríguez-Guillén R, et al. Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population. Diabetes. 2012;61(12):3314-21. https:// doi.org/10.2337/db11-0550

  45. Weissglas-Volkov D, Aguilar-Salinas CA, Nikkola E, Deere KA, Cruz- Bautista I, Arellano-Campos O, et al. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J Med Genet. 2013;50(5):298-308. https://doi.org/10.1136/jmedgenet-2012-101461

  46. Villalobos-Comparan M, Flores-Dorantes M, Villarreal-Molina M, Rodríguez- Cruz M, García-Ulloa AC, Robles L, et al. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring). 2008;16(10):2296-301. https://doi.org/10.1038/oby.2008.367

  47. Rudolph A, Chang-Claude J, Schmidt MK. Gene-environment interaction and risk of breast cancer. Br J Cancer. 2016;114(2):125-33. https://doi. org/10.1038/bjc.2015.439




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2019;61

ARTíCULOS SIMILARES

CARGANDO ...